Non-opioid Pain Patch Market Size

Non-opioid Pain Patch Market Size

The global non-opioid pain patch market size was valued at around USD 828.3 million in 2023 and is estimated to grow at 6.6% CAGR from 2024 to 2032. Non-opioid pain patches are transdermal patches that administer medication through the skin, offering localized pain relief without resorting to opioid-based drugs. These patches effectively manage a range of pain types, including chronic, neuropathic, musculoskeletal, and post-surgical pain, all while avoiding the addictive potential and side effects commonly linked to opioids.

The rise in opioid prescriptions has increased the demand for safer alternatives, notably non-opioid pain patches. In 2022, the U.S. witnessed 14,716 deaths due to drug overdoses involving prescription opioids, as reported by the National Institute on Drug Abuse. Such alarming figures have highlighted the importance of non-opioid pain management solutions. Additionally, the growing prevalence of pain-related disorders fuels this market's expansion. The National Institutes of Health (NIH) highlights a significant opportunity, estimating around 50 million Americans suffer from chronic pain. Non-opioid pain patches stand out from the rest of alternatives, boasting advantages like controlled drug release, a diminished risk of addiction, and fewer side effects. These benefits are pivotal in propelling the growth of the non-opioid pain patch market.
 

Furthermore, heightened research and development (R&D) efforts in pain management treatments bolster the market's growth. The NIH Heal Initiative is dedicated to enhancing chronic pain treatments and curbing the rates of opioid use disorder (OUD) and overdoses in the U.S. Such endeavors pave the way for the emergence of safer alternatives, like non-opioid pain patches, signaling considerable market growth in the years ahead.